CN115073441A - Synthetic method of topramezone intermediate - Google Patents

Synthetic method of topramezone intermediate Download PDF

Info

Publication number
CN115073441A
CN115073441A CN202110267253.5A CN202110267253A CN115073441A CN 115073441 A CN115073441 A CN 115073441A CN 202110267253 A CN202110267253 A CN 202110267253A CN 115073441 A CN115073441 A CN 115073441A
Authority
CN
China
Prior art keywords
reaction
compound
base
synthesis
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110267253.5A
Other languages
Chinese (zh)
Other versions
CN115073441B (en
Inventor
李志清
王嵩
宋健
郝守志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Rainbow Biotech Co Ltd
Original Assignee
Shandong Rainbow Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Rainbow Biotech Co Ltd filed Critical Shandong Rainbow Biotech Co Ltd
Priority to CN202110267253.5A priority Critical patent/CN115073441B/en
Publication of CN115073441A publication Critical patent/CN115073441A/en
Application granted granted Critical
Publication of CN115073441B publication Critical patent/CN115073441B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthesis method of a sulfuryl pyraflufen intermediate, which comprises the following reaction steps: a. reacting the compound A with dibromoformyloxime in a first solvent under the action of first alkali to generate an intermediate I; b. the intermediate I and isobutene undergo a pericyclic reaction under the action of a second base to generate a sulfonepyrazoxazole intermediate II. The synthesis method has the advantages of high reaction speed, high product purity and yield, mild reaction conditions, extensive synthesis process, optimized reaction conditions, reduced reaction equipment cost, easy separation of the obtained product and simplified production process.

Description

Synthetic method of topramezone intermediate
Technical Field
The invention relates to a sulfonylpyrafluzole intermediate, in particular to a synthetic method of 3- [ [5- (difluoromethoxy) -1-methyl-3- (trifluoromethyl) pyrazol-4-yl ] methylsulfonyl ] -5, 5-dimethyl-4H-1, 2-oxazole, belonging to the technical field of organic synthesis.
Background
Sulfoxaden is developed by Nippon combinatorial chemical having the structure shown below:
Figure BDA0002972617160000011
it can be used as a pre-emergence soil treatment for most crop fields. The applied sulpyrazone is absorbed by young roots and young buds of weeds, inhibits the early growth of seedlings, destroys meristems and coleoptiles, and is a serious potential inhibitor in the biosynthesis of VLCFA (very long side chain fatty acid) (C20-C30) in plants.
3- [ [5- (difluoromethoxy) -1-methyl-3- (trifluoromethyl) pyrazol-4-yl ] methylsulfonyl ] -5, 5-dimethyl-4H-1, 2-oxazole as a key intermediate in the synthesis of sulfonepyrazoxazole, which is disclosed in the prior art, for example, CN102666503, can be synthesized using the following pathway:
Figure BDA0002972617160000012
the method specifically comprises the following steps: under the alkaline condition, 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol, formaldehyde aqueous solution and 5, 5-dimethyl-4, 5-dihydro isoxazole sulfamidine hydrochloride are subjected to condensation reaction in water and then alkylated with freon to obtain the key intermediate of the sulfuryl pyrafluzole
Figure BDA0002972617160000021
However, the synthesis method has the defects of low product yield, difficult treatment of sulfur-containing wastewater, three wastes and the like.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a synthesis method of a sulfuryl pyraflufen intermediate, which has the advantages of mild reaction conditions, high product yield, less three wastes generated in the reaction process and the like.
In order to achieve the purpose, the invention adopts the following technical scheme:
a synthetic method of a sulfuryl pyraflufen intermediate comprises the following reaction steps:
a. the compound A and dibromoformyl oxime react in a first solvent under the action of a first base to generate an intermediate I:
Figure BDA0002972617160000022
and
b. the intermediate I and isobutene undergo a cyclotomic reaction under the action of a second base to generate the intermediate II of the sulfonepyrazoxazole:
Figure BDA0002972617160000031
further: the step a comprises the following steps: dissolving a compound A in a first solvent, and adding a first base for reaction; followed by the addition of dibromoformyloxime.
Further: in the step a, the reaction temperature is 0-60 ℃.
Further: the first alkali is sodium bicarbonate and/or potassium bicarbonate; and the reaction molar ratio n of compound a to the first base (compound a): n (first base) is 1:1.05 to 1: 1.3.
Further: the first solvent is an alcohol.
Further: the first solvent is methanol or ethanol.
Further: in the step b, the reaction temperature is-20 ℃ to 50 ℃.
Further: the second alkali is sodium hydroxide and/or potassium hydroxide; and the reaction molar ratio of the intermediate I to isobutylene is n (intermediate I): n (isobutylene) is 1:1.1 to 1: 1.5.
The invention provides a novel method for synthesizing a key intermediate of sulfone pyraflufen-ethyl, which comprises the steps of reacting a compound A with dibromoformyloxime to generate an intermediate I, and then carrying out a cyclization reaction on the intermediate I and isobutene under an alkaline condition to finally obtain the intermediate of the sulfone pyraflufen-ethyl
Figure BDA0002972617160000032
Compared with the existing synthesis method, the synthesis method has the following characteristics: (1) the reaction condition is mild, high temperature and high pressure are not needed, and the requirement on equipment is low; (2) the reaction selectivity is high, the reaction yield is high, and the yield is over 80 percent; (3) the post-treatment is simple and extensive, and is suitable for large-scale production; (4) no catalyst is needed; (5) the three wastes generated in the synthesis process are less and easy to treat.
Detailed Description
The invention provides a novel method for synthesizing a key intermediate 3- [ [5- (difluoromethoxy) -1-methyl-3- (trifluoromethyl) pyrazol-4-yl ] methylsulfonyl ] -5, 5-dimethyl-4H-1, 2-oxazole of sulfonepyrafluzole, which adopts the following synthesis mechanism:
Figure BDA0002972617160000041
specifically, the synthesis step of the intermediate 3- [ [5- (difluoromethoxy) -1-methyl-3- (trifluoromethyl) pyrazol-4-yl ] methylsulfonyl ] -5, 5-dimethyl-4H-1, 2-oxazole comprises the following steps: a. reacting the compound A with dibromoformyloxime in a first solvent under the action of first alkali to generate an intermediate I; and b, the intermediate I and isobutene have a cycloreaction under the action of a second base to generate the 3- [ [5- (difluoromethoxy) -1-methyl-3- (trifluoromethyl) pyrazol-4-yl ] methylsulfonyl ] -5, 5-dimethyl-4H-1, 2-oxazole (intermediate II) disclosed by the application.
Wherein, in the step a, the reaction temperature is 0-60 ℃; the first alkali can adopt sodium bicarbonate and/or potassium bicarbonate; and the reaction molar ratio n of compound a to the first base (compound a): n (first base) is 1:1.05 to 1: 1.3; and the first solvent is an alcohol, preferably methanol or ethanol.
In the step b, the reaction temperature is-20 ℃ to 50 ℃; the second alkali is sodium hydroxide and/or potassium hydroxide; and the reaction molar ratio of the intermediate I to the isobutene is n (intermediate I): n (isobutylene) is 1:1.1 to 1: 1.5.
The technical solution of the present invention is further described below with reference to specific examples, but the present invention is not limited to the following examples. The raw materials used in the present invention are commercially available if not otherwise specified.
Example 1
Adding 13.1g of compound A into 100ml of ethanol at room temperature and stirring until the mixture is clear; then adding 4.2g of sodium bicarbonate to react for 1 hour; then adding 10.1g of dibromoformyloxime, continuously reacting for 4hr at room temperature, and cooling to-10 ℃ after HPLC detection reaction; adding 2.5g of sodium hydroxide, introducing 3.1g of isobutene, detecting the reaction by HPLC after 2 hours, and spin-drying the solvent to obtain 16.19g of oil, wherein the purity is 92.1% and the total yield in two steps is 83%.
Example 2:
adding 13.1g of the compound A into 100ml of ethanol at room temperature and stirring until the mixture is clear; then 5.5g of potassium bicarbonate is added for reaction for 1 hour; then adding 10.1g of dibromoformyloxime, continuously reacting for 4 hours at room temperature, and cooling to-10 ℃ after the HPLC detection reaction is finished; adding 3.63g of potassium hydroxide, introducing 3.1g of isobutene, after 2 hours, detecting by HPLC to finish the reaction, and spin-drying the solvent to obtain 16.4g of oily substance with the purity of 93.3% and the total yield of the two steps of 85.2%.
Example 3:
13.1g of Compound A are added to 100ml of methanol and stirred at 15 ℃ until clear; then 5.5g of potassium bicarbonate is added to react for 1 hour at the temperature of 15 ℃; then adding 10.1g of dibromoformyloxime, continuing the heat preservation reaction at the temperature for 4 hours, reducing the temperature to-20 ℃ after the HPLC detection reaction is finished, adding 3.63g of potassium hydroxide, introducing 3.1g of isobutene, completing the HPLC detection reaction after 4 hours, and spin-drying the solvent to obtain 16.55g of oily matter, wherein the purity is 91.7 percent through detection, and the total yield of the two steps is 84.5 percent.
Example 4:
13.1g of Compound A are added to 100ml of methanol and stirred at 30 ℃ until clear; then 6g of potassium bicarbonate is added to react for 1 hour at the temperature of 30 ℃; then adding 10.1g of dibromoformyloxime, continuing to carry out heat preservation reaction at the temperature for 4 hours, supplementing 3.95g of potassium hydroxide after the HPLC detection reaction is finished, introducing 3.65g of isobutene to continue the reaction at the temperature, finishing the HPLC detection reaction after 4 hours, and drying the solvent by spinning to obtain 16.07g of oily matter, wherein the purity is 90.2 percent by detection, and the total yield of the two steps is 80.7 percent.
Example 5:
adding 13.1g of the compound A into 100ml of ethanol at room temperature and stirring until the mixture is clear; then 4.2g of sodium bicarbonate is added to react for 1 hour at room temperature; and then adding 10.1g of dibromoformyloxime, continuing to react for 4 hours at room temperature, cooling to 0 ℃ after the HPLC detection reaction is finished, supplementing 2.71g of sodium hydroxide and introducing 3.65g of isobutene, completing the HPLC detection reaction after 2 hours, and spin-drying the solvent to obtain 16.14g of oily matter, wherein the purity is 92.6 percent through detection, and the total yield of the two steps is 83.2 percent.
The present invention has been described in detail with reference to the preferred embodiments. However, variations and additions to the embodiments will become apparent to those of ordinary skill in the art upon a reading of the foregoing description. It is the intention of the applicants that all such variations and additions fall within the scope of the claims. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Any modification and improvement of this product, and the substitution and use of the same or similar substances within the scope or range of patents, shall fall within the scope of protection of this invention.

Claims (8)

1. A synthetic method of a sulfuryl pyraflufen intermediate is characterized by comprising the following steps: the method comprises the following reaction steps:
a. the compound A and dibromoformyl oxime react in a first solvent under the action of a first base to generate an intermediate I:
Figure FDA0002972617150000011
and
b. the intermediate I and isobutene undergo a pericyclic reaction under the action of a second base to generate a sulfonepyrazoxazole intermediate II:
Figure FDA0002972617150000012
2. the method of synthesis according to claim 1, characterized in that: the step a comprises the following steps: dissolving a compound A in a first solvent, and adding a first base for reaction; followed by the addition of dibromoformyloxime.
3. The synthesis method according to claim 1 or 2, characterized in that: in the step a, the reaction temperature is 0-60 ℃.
4. The synthesis method according to claim 1 or 2, characterized in that: the first alkali is sodium bicarbonate and/or potassium bicarbonate; and the reaction molar ratio n of compound a to the first base (compound a): n (first base) is 1:1.05 to 1: 1.3.
5. The synthesis method according to claim 1 or 2, characterized in that: the first solvent is an alcohol.
6. The method of synthesis according to claim 5, characterized in that: the first solvent is methanol or ethanol.
7. The synthesis method according to claim 1 or 2, characterized in that: in the step b, the reaction temperature is-20 ℃ to 50 ℃.
8. The synthesis method according to claim 1 or 2, characterized in that: the second alkali is sodium hydroxide and/or potassium hydroxide; and the reaction molar ratio of the intermediate I to isobutylene is n (intermediate I): n (isobutylene) is 1:1.1 to 1: 1.5.
CN202110267253.5A 2021-03-11 2021-03-11 Synthesis method of topiramate intermediate Active CN115073441B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110267253.5A CN115073441B (en) 2021-03-11 2021-03-11 Synthesis method of topiramate intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110267253.5A CN115073441B (en) 2021-03-11 2021-03-11 Synthesis method of topiramate intermediate

Publications (2)

Publication Number Publication Date
CN115073441A true CN115073441A (en) 2022-09-20
CN115073441B CN115073441B (en) 2024-04-02

Family

ID=83241289

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110267253.5A Active CN115073441B (en) 2021-03-11 2021-03-11 Synthesis method of topiramate intermediate

Country Status (1)

Country Link
CN (1) CN115073441B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113372288A (en) * 2021-06-02 2021-09-10 安徽久易农业股份有限公司 Synthetic method of topramezone pesticide intermediate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111574511A (en) * 2020-06-28 2020-08-25 安徽久易农业股份有限公司 Synthesis method and application of sulfuryl pyraflufen
WO2020240392A1 (en) * 2019-05-24 2020-12-03 Pi Industries Limited Process for preparation of pyroxasulfone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020240392A1 (en) * 2019-05-24 2020-12-03 Pi Industries Limited Process for preparation of pyroxasulfone
CN111574511A (en) * 2020-06-28 2020-08-25 安徽久易农业股份有限公司 Synthesis method and application of sulfuryl pyraflufen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113372288A (en) * 2021-06-02 2021-09-10 安徽久易农业股份有限公司 Synthetic method of topramezone pesticide intermediate

Also Published As

Publication number Publication date
CN115073441B (en) 2024-04-02

Similar Documents

Publication Publication Date Title
CN113754648B (en) Preparation method of xaflufen and intermediate thereof
CN113135867B (en) S- (5, 5-dimethyl-4, 5-dihydroisoxazol-3-yl) ethyl acetate and synthetic method and application thereof
CN113754647B (en) Synthesis method of sulfuryl pyraflufen-ethyl and intermediate thereof
CN115073441A (en) Synthetic method of topramezone intermediate
CN113372283B (en) Synthetic method of 2-methylamino-4-methoxy-6-methyl-1, 3, 5-triazine
CN117229187B (en) Synthesis method of thioimine ester compound
KR100355184B1 (en) Process for the preparation of isoflavones
CN108752289B (en) Synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
CN115872849A (en) Method for preparing 2, 5-dimethylphenylacetic acid
CN114230531B (en) Synthesis method of metconazole
CN116102510A (en) Preparation method of 3-bromo-5, 5-dimethyl-4, 5-dihydro-isoxazole
ES2524474T3 (en) Process for the production of 3- [5- [4- (cyclopentyloxy) -2-hydroxybenzoyl] -2- [3- (hydroxy-1,2-benzisoxazol-6-yl) methoxy] phenyl] propionate and intermediate ester for this process
CN113185433A (en) Preparation method of menadione sodium bisulfite
KR910009271B1 (en) 1,1-dioxopenicillanoyl oxymethyl d-6-(alpha-cmethyleneamino phenylacetamide)-penicillanate and p-tolluenesulfonic acid salts
CN117229273B (en) Preparation method of metazachlor and intermediate thereof
CN114716428B (en) Method for preparing metazopyr intermediate
CN104478715A (en) Preparation method of compound
CN117924265B (en) Synthesis method of pyrifos
CN108383822B (en) Preparation method of 2-chloro-1- (6-fluoro-3, 4-dihydro-2H-1-benzopyran-2-yl) ethanone
CN102718663A (en) Synthesis method of 5-chloro-1-indene amine
IE45729B1 (en) Rifamycin sv derivatives
EP3609877B1 (en) Process for the synthesis of firocoxib
RU1810343C (en) 4,4-dinitro - 2,3 - dihydroxytetrahydrofuran and a method of its synthesis
SU1761745A1 (en) Method of 1,1,4,4-tetranitrobutane diol-2,3 synthesis
CN116425681A (en) Green synthesis method of cyazofamid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant